CytoReason Ltd.

CytoReason has developed the first machine learning model of the immune system. The technology is based on over a decade of research at Stanford and the Technion. Our model leverages literature and measurement data from public and proprietary sources. We partner with top-pharma and research-institutions, de-risking their research while training our model. These collaborations span discovery, development and post-market stages by identifying biomarkers, modeling compound’s mode of action, and disease research. Our work is supporting patient stratification, companion diagnostics, prediction of adverse events and indication expansion.